News | April 08, 2026
Dabur reports steady domestic growth amid global headwinds in Q4 FY26
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Jain will have oversight of Brinton's domestic operations, including business development, sales, and marketing
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
Subscribe To Our Newsletter & Stay Updated
